Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep574 | Endocrine-Related Cancer | ECE2022

Pregnandiene-structures coupled with anti-inflammatory moieties as inhibitors of the 5α-reductase activity

Cabeza Marisa , Soriano Juan , Bratoeff Eugene , Heuze Yvonne

Proliferative inflammatory atrophy and prostatic intraepithelial neoplasia are the first signs of prostate cancer. This inflammatory etiology, together with the infiltration of immune cells, could lead to the binding of the cytokines with cancer cells, forming a population that could initiate tumor growth. [1] Androgens also play an essential role in prostate tumor growth, as is well documented. [2] Androgen deprivation therapy is currently the gold standard for hormone-sensit...

ea0081ep577 | Endocrine-Related Cancer | ECE2022

Novel steroidal derivatives preventing prostate dihydrotestosterone synthesis

Cabeza Marisa , Carlos Lopez-Lezama Juan , Soriano Juan , Valencia-Islas Norma , Heuze Yvonne

It is well-known that the increase of intraprostatic levels of 5α-dihydrotestosterone is related to the development of prostatic pathologies such as benign prostatic hyperplasia and prostate cancer. So finasteride and dutasteride-based therapies have been used to improve these diseases. These drugs are potent inhibitors of the enzyme 5α-reductase, which is found in the androgen-dependent tissues. This enzyme is responsible for converting testosterone into dihydrotest...